http://medicineworld.org/news/prostateNews.html MedicineWorld.Org brings daily prostate cancer news from various sources to keep you updated on the latest events in the world on this topic. Medicineworld heart watch news service is the most comprehensive heart watch news service on the internet. We keep an archive of previous few days of news on this site. Please go down through the list to find the older news items. Mon, 23 Aug 2010 13:12:17 GMT en-us http://medicineworld.org/images/blogs/prostate.jpg http://medicineworld.org/news/prostateNews.html 107 99 http://medicineworld.org/stories/lead/8-2010/cost-of-prostate-cancer-care.html http://medicineworld.org/stories/lead/8-2010/cost-of-prostate-cancer-care.html Mon, 23 Aug 2010 13:12:17 GMT A new analysis has observed that short-term and long-term costs of prostate cancer care vary considerably based on which therapy strategy a man initially receives. Published early online in Cancer, a peer-evaluated journal of the American Cancer Society, the study finds that therapys that appears to be less expensive in the short-term may have higher long-term costs........ ]]> http://medicineworld.org/stories/lead/8-2010/surgery-radiation-or-hormone.html http://medicineworld.org/stories/lead/8-2010/surgery-radiation-or-hormone.html Mon, 23 Aug 2010 13:12:17 GMT Surgery for localized prostate cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, as per a newly released study led by scientists at UCSF. The differences among therapies were more prominent at higher levels of cancer risk, and suggest, the scientists say, that in a number of cases surgery should play a greater role in therapy strategies for prostate cancer patients that is likely to recur or spread........ ]]> http://medicineworld.org/stories/lead/9-2009/impact-of-income-on-prostate-cancer.html http://medicineworld.org/stories/lead/9-2009/impact-of-income-on-prostate-cancer.html Mon, 23 Aug 2010 13:12:17 GMT Prostate cancer patients who is living on low income is likely to die earlier compared to prostate cancer patients who are economically in a more advantageous position. That is the finding of a new study from Swiss researchers to be published in the December 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study's findings indicate that poor prostate cancer patients receive worse care than their wealthier counterparts........ ]]> http://medicineworld.org/stories/lead/6-2009/dramatic-outcomes-in-prostate-cancer-study.html http://medicineworld.org/stories/lead/6-2009/dramatic-outcomes-in-prostate-cancer-study.html Mon, 23 Aug 2010 13:12:17 GMT Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug treatment that was used in combination with standardized hormone therapy and radiation treatment. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab. In these two cases, physicians say the approach initiated the death of a majority of cancer cells and caused the tumors to shrink dramatically, allowing surgery. In both cases, the aggressive tumors had grown well beyond the prostate into the abdominal areas........ ]]> http://medicineworld.org/stories/lead/6-2009/dynamic-stroma-microenvironment.html http://medicineworld.org/stories/lead/6-2009/dynamic-stroma-microenvironment.html Mon, 23 Aug 2010 13:12:17 GMT As stroma the supportive framework of the prostate gland react to prostate cancer, changes in the expression of genes occur that induce the formation of new structures such as blood vessels, nerves and parts of nerves, said scientists at Baylor College of Medicine in a report that appears in the current issue of the journal Clinical Cancer Research....... ]]> http://medicineworld.org/stories/lead/4-2009/new-drug-for-prostate-cancer.html http://medicineworld.org/stories/lead/4-2009/new-drug-for-prostate-cancer.html Mon, 23 Aug 2010 13:12:17 GMT A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels a marker for tumor growth in men with advanced prostate cancer for whom traditional therapy options have failed. The study, led by scientists at Memorial Sloan-Kettering Cancer Center (MSKCC), is published recently in Science Express, the online version of the journal Science....... ]]> http://medicineworld.org/stories/lead/4-2009/treating-drug-resistant-prostate-cancer.html http://medicineworld.org/stories/lead/4-2009/treating-drug-resistant-prostate-cancer.html Mon, 23 Aug 2010 13:12:17 GMT A new treatment for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Of 30 men who received low doses of one the drugs in a multisite phase I/II trial designed to evaluate safety, 22 showed a sustained decline in the level of prostate specific antigen (PSA) in their blood. Phase III clinical trials are planned to evaluate the drug's effect on survival in a large group of patients with metastatic prostate cancer........ ]]> http://medicineworld.org/cancer/lead/10-2007/prostate-cancer-may-encourage-spread.html http://medicineworld.org/cancer/lead/10-2007/prostate-cancer-may-encourage-spread.html Mon, 23 Aug 2010 13:12:17 GMT A popular prostate cancer therapy called androgen deprivation treatment may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins scientists suggests. Eventhough the finding could eventually lead to changes in this standard therapy for a sometimes deadly disease, the Johns Hopkins scientists caution that their discovery is far too preliminary for patients with prostate cancer or physicians to stop using it. The treatment is effective at slowing tumor growth, they emphasized........ ]]> http://medicineworld.org/cancer/lead/7-2007/for-colorectal-and-prostate-cancer.html http://medicineworld.org/cancer/lead/7-2007/for-colorectal-and-prostate-cancer.html Mon, 23 Aug 2010 13:12:17 GMT A study led by scientists at the Keck School of Medicine of the University of Southern California (USC) has observed that one of seven genetic risk factors previously identified as increasing the probability of developing prostate cancer also increases the probability of developing colorectal cancer. As in the prior prostate cancer study, which was also conducted by USC scientists and reported in the April 2007 edition of Nature Genetics, the colorectal cancer risk factor is located in a region of the human genome devoid of known genes on chromosome 8. The studys complete findings would be reported in the July 8 online edition of Nature Genetics........ ]]> http://medicineworld.org/cancer/lead/12-2006/older-men-with-early-prostate-cancer.html http://medicineworld.org/cancer/lead/12-2006/older-men-with-early-prostate-cancer.html Mon, 23 Aug 2010 13:12:17 GMT Recent findings from an observational study by scientists at the University of Pennsylvania School of Medicine suggest that men between 65 and 80 years of age who received therapy for early stage, localized prostate cancer lived significantly longer than men who did not receive therapy. The study would be reported in the December 13th issue of the Journal of the American Medical Association........ ]]> http://medicineworld.org/cancer/lead/11-2006/six-months-of-hormone-therapy.html http://medicineworld.org/cancer/lead/11-2006/six-months-of-hormone-therapy.html Mon, 23 Aug 2010 13:12:17 GMT Patients with prostate cancer treated with either radiation or surgery who use hormone treatment for longer than six months do not survive any longer than patients who use the therapy for a shorter amount of time, as per a research studypresented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia........ ]]> http://medicineworld.org/cancer/lead/11-2006/why-men-with-prostate-cancer-avoid-radiation.html http://medicineworld.org/cancer/lead/11-2006/why-men-with-prostate-cancer-avoid-radiation.html Mon, 23 Aug 2010 13:12:17 GMT Negative perceptions about radiation treatment can strongly influence a prostate cancer patient's choice to avoid external beam radiation treatment, even though studies have proven the therapy to be as safe and effective as other therapys for the disease, including surgery, as per a research studypresented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia........ ]]> http://medicineworld.org/cancer/lead/9-2006/gene-therapy-for-prostate-cancer.html http://medicineworld.org/cancer/lead/9-2006/gene-therapy-for-prostate-cancer.html Mon, 23 Aug 2010 13:12:17 GMT Scientists at Baylor College of Medicine (BCM) are hoping a new gene treatment that takes a gene called RTVP-1 directly into the prostate tumor will prove effective in preventing recurrence of the disease. The first phase of the study is designed to test the safety of the therapy and determine the proper dosage of gene, said Dr. Dov Kadmon, professor of urology at BCM. It will be carried out in the department of urology at BCM as well as at Ben Taub General Hospital, The Methodist Hospital and Michael E. DeBakey Veterans Affairs Medical Center........ ]]> http://medicineworld.org/cancer/lead/7-2006/pomegranate-juice.html http://medicineworld.org/cancer/lead/7-2006/pomegranate-juice.html Mon, 23 Aug 2010 13:12:17 GMT http://medicineworld.org/cancer/lead/6-2006/suggest-your-news-item-to-medicineworld.html http://medicineworld.org/cancer/lead/6-2006/suggest-your-news-item-to-medicineworld.html Mon, 23 Aug 2010 13:12:17 GMT